{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:09:19Z","timestamp":1791950959669,"version":"4.3.4"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-024-00740-0","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:02:02Z","timestamp":1728496922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The epidemiology of gram-negative bacteremia in Lebanon: a study in four hospitals"],"prefix":"10.1186","volume":"23","author":[{"given":"Janane","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Abdessamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Mina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Haykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawad","family":"Abi Assaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Alameddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Bourji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Abdulaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Tomassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"El Ahmadieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques E.","family":"Mokhbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Moghnieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso J.","family":"Rodriguez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola","family":"Husni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"issue":"11","key":"740_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/ofid\/ofaa461","volume":"7","author":"A Santoro","year":"2020","unstructured":"Santoro A, Franceschini E, Meschiari M, et al. Epidemiology and risk factors associated with mortality in consecutive patients with bacterial bloodstream infection: impact of MDR and XDR bacteria. Open Forum Infect Dis. 2020;7(11):461. https:\/\/doi.org\/10.1093\/ofid\/ofaa461.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"740_CR2","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/CMR.00084-17","volume":"31","author":"N Kavanagh","year":"2018","unstructured":"Kavanagh N, Ryan EJ, Widaa A, et al. Staphylococcal osteomyelitis: disease progression, treatment challenges, and future directions. Clin Microbiol Rev. 2018;31(2):e00084-e117. https:\/\/doi.org\/10.1128\/CMR.00084-17.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"740_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"11","key":"740_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/ofid\/ofaa472","volume":"7","author":"NM Douglas","year":"2020","unstructured":"Douglas NM, Hennessy JN, Currie BJ, Baird RW. Trends in bacteremia over 2 decades in the top end of the northern territory of Australia. Open Forum Infect Dis. 2020;7(11):472. https:\/\/doi.org\/10.1093\/ofid\/ofaa472.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"740_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/cid\/ciaa210","volume":"72","author":"M Bonten","year":"2021","unstructured":"Bonten M, Johnson JR, van den Biggelaar AHJ, et al. Epidemiology of Escherichia coli bacteremia: a systematic literature review. Clin Infect Dis. 2021;72(7):1211\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaa210.","journal-title":"Clin Infect Dis"},{"key":"740_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijid.2018.03.022","volume":"71","author":"B Islas-Mu\u00f1oz","year":"2018","unstructured":"Islas-Mu\u00f1oz B, Volkow-Fern\u00e1ndez P, Ibanes-Guti\u00e9rrez C, Villamar-Ram\u00edrez A, Vilar-Compte D, Cornejo-Ju\u00e1rez P. Bloodstream infections in cancer patients. Risk factors associated with mortality. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2018;71:59\u201364. https:\/\/doi.org\/10.1016\/j.ijid.2018.03.022.","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"issue":"4","key":"740_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"EM Trecarichi","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, et al. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2015;21(4):337\u201343. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.022.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"10","key":"740_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/phar.1636","volume":"35","author":"KS Kaye","year":"2015","unstructured":"Kaye KS, Pogue JM. Infections caused by resistant gram-negative bacteria: epidemiology and management. Pharmacother J Hum Pharmacol Drug Ther. 2015;35(10):949\u201362. https:\/\/doi.org\/10.1002\/phar.1636.","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"2","key":"740_CR9","doi-asserted-by":"publisher","first-page":"e00234","DOI":"10.1128\/CMR.00234-20","volume":"34","author":"CL Holmes","year":"2021","unstructured":"Holmes CL, Anderson MT, Mobley HLT, Bachman MA. Pathogenesis of gram-negative bacteremia. Clin Microbiol Rev. 2021;34(2):e00234-e320. https:\/\/doi.org\/10.1128\/CMR.00234-20.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"740_CR10","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/S1473-3099(18)30414-6","volume":"18","author":"RA Moghnieh","year":"2018","unstructured":"Moghnieh RA, Kanafani ZA, Tabaja HZ, Sharara SL, Awad LS, Kanj SS. Epidemiology of common resistant bacterial pathogens in the countries of the Arab League. Lancet Infect Dis. 2018;18(12):e379\u201394. https:\/\/doi.org\/10.1016\/S1473-3099(18)30414-6.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"740_CR11","doi-asserted-by":"publisher","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Hsueh PR, Mendes RE, et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7):e00355-e419. https:\/\/doi.org\/10.1128\/AAC.00355-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"740_CR12","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/22221751.2020.1799721","volume":"9","author":"Y Hu","year":"2020","unstructured":"Hu Y, Liu C, Shen Z, et al. Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008\u20132018. Emerg Microbes Infect. 2020;9(1):1771\u20139. https:\/\/doi.org\/10.1080\/22221751.2020.1799721.","journal-title":"Emerg Microbes Infect"},{"key":"740_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.799084","author":"D Kim","year":"2022","unstructured":"Kim D, Yoon EJ, Hong JS, et al. Major bloodstream infection-causing bacterial pathogens and their antimicrobial resistance in South Korea, 2017\u20132019: phase I report from Kor-GLASS. Front Microbiol. 2022. https:\/\/doi.org\/10.3389\/fmicb.2021.799084.","journal-title":"Front Microbiol"},{"issue":"1","key":"740_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13756-019-0545-z","volume":"8","author":"L Tian","year":"2019","unstructured":"Tian L, Zhang Z, Sun Z. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998\u20132017). Antimicrob Resist Infect Control. 2019;8(1):86. https:\/\/doi.org\/10.1186\/s13756-019-0545-z.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10","key":"740_CR15","doi-asserted-by":"publisher","first-page":"e0223467","DOI":"10.1371\/journal.pone.0223467","volume":"14","author":"P Kreidl","year":"2019","unstructured":"Kreidl P, Kirchner T, Fille M, Heller I, Lass-Fl\u00f6rl C, Orth-H\u00f6ller D. Antibiotic resistance of blood cultures in regional and tertiary hospital settings of Tyrol, Austria (2006\u20132015): impacts & trends. PLoS ONE. 2019;14(10):e0223467. https:\/\/doi.org\/10.1371\/journal.pone.0223467.","journal-title":"PLoS ONE"},{"issue":"12","key":"740_CR16","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.ajic.2018.06.019","volume":"46","author":"H Hattori","year":"2018","unstructured":"Hattori H, Maeda M, Nagatomo Y, et al. Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan. Am J Infect Control. 2018;46(12):e75\u20139. https:\/\/doi.org\/10.1016\/j.ajic.2018.06.019.","journal-title":"Am J Infect Control"},{"issue":"1","key":"740_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13756-017-0297-6","volume":"7","author":"ZA Kanafani","year":"2018","unstructured":"Kanafani ZA, Zahreddine N, Tayyar R, et al. Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon. Antimicrob Resist Infect Control. 2018;7(1):9. https:\/\/doi.org\/10.1186\/s13756-017-0297-6.","journal-title":"Antimicrob Resist Infect Control"},{"key":"740_CR18","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e196","author":"D Kim","year":"2022","unstructured":"Kim D, Lee H, Sik CJ, et al. The changes in epidemiology of imipenem-resistant Acinetobacter baumannii bacteremia in a pediatric intensive care unit for 17 years. J Korean Med Sci. 2022. https:\/\/doi.org\/10.3346\/jkms.2022.37.e196.","journal-title":"J Korean Med Sci"},{"key":"740_CR19","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2217\/fmb-2020-0079","volume":"15","author":"M Osman","year":"2020","unstructured":"Osman M, Halimeh BF, Rafei R, et al. Investigation of an\u00a0XDR-Acinetobacter baumannii ST2 outbreak in an intensive care unit of a Lebanese tertiary care hospital. Future Microbiol. 2020;15:1535\u201342. https:\/\/doi.org\/10.2217\/fmb-2020-0079.","journal-title":"Future Microbiol"},{"issue":"4","key":"740_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/antibiotics13040320","volume":"13","author":"HA Hadi","year":"2024","unstructured":"Hadi HA, Dargham SR, Eltayeb F, et al. Epidemiology, clinical, and microbiological characteristics of multidrug-resistant gram-negative bacteremia in Qatar. Antibiotics. 2024;13(4):320\u2013320. https:\/\/doi.org\/10.3390\/antibiotics13040320.","journal-title":"Antibiotics"},{"issue":"1","key":"740_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2160\/ejmm.2019.282381","volume":"28","author":"HS Faidah","year":"2019","unstructured":"Faidah HS, Al-Said HM, Moustafa A, Ashgar SS, Johargy A. A twelve year retrospective study assessing the prevalence of bloodstream infections causing pathogens at a tertiary care hospital in holy Makkah, Saudi Arabia. Egypt J Med Microbiol. 2019;28(1):31\u20139. https:\/\/doi.org\/10.2160\/ejmm.2019.282381.","journal-title":"Egypt J Med Microbiol"},{"key":"740_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jgar.2021.09.008","volume":"27","author":"S Haddad","year":"2021","unstructured":"Haddad S, Jabbour JF, Hindy JR, et al. Bacterial bloodstream infections and patterns of resistance in patients with haematological malignancies at a tertiary centre in Lebanon over 10 years. J Glob Antimicrob Resist. 2021;27:228\u201335.","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"740_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3947\/ic.2019.51.2.130","volume":"51","author":"M Hyun","year":"2019","unstructured":"Hyun M, Lee JY, Ah KH, Ryu SY. Comparison of Escherichia coli and Klebsiella pneumoniae acute pyelonephritis in Korean patients. Infect Chemother. 2019;51(2):130\u201341. https:\/\/doi.org\/10.3947\/ic.2019.51.2.130.","journal-title":"Infect Chemother"},{"issue":"6","key":"740_CR24","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijantimicag.2018.08.013","volume":"52","author":"H Lishman","year":"2018","unstructured":"Lishman H, Costelloe C, Hopkins S, et al. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study. Int J Antimicrob Agents. 2018;52(6):790\u20138. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.08.013.","journal-title":"Int J Antimicrob Agents"},{"key":"740_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.888205","author":"X Yang","year":"2022","unstructured":"Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: a worldwide report. Front Public Health. 2022. https:\/\/doi.org\/10.3389\/fpubh.2022.888205.","journal-title":"Front Public Health"},{"issue":"3","key":"740_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.5811\/westjem.2020.1.45944","volume":"21","author":"PC Chardavoyne","year":"2020","unstructured":"Chardavoyne PC, Kasmire KE. Appropriateness of antibiotic prescriptions for urinary tract infections. West J Emerg Med. 2020;21(3):633\u20139. https:\/\/doi.org\/10.5811\/westjem.2020.1.45944.","journal-title":"West J Emerg Med"},{"issue":"4","key":"740_CR27","doi-asserted-by":"publisher","first-page":"106104","DOI":"10.1016\/j.ijantimicag.2020.106104","volume":"56","author":"J Al Salman","year":"2020","unstructured":"Al Salman J, Al Dabal L, Bassetti M, et al. Management of infections caused by WHO critical priority gram-negative pathogens in Arab countries of the Middle East: a consensus paper. Int J Antimicrob Agents. 2020;56(4):106104. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106104.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"740_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13756-020-0685-1","volume":"9","author":"PY Chia","year":"2020","unstructured":"Chia PY, Sengupta S, Kukreja A, Ponnampalavanar SSL, Ng OT, Marimuthu K. The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms. Antimicrob Resist Infect Control. 2020;9(1):29. https:\/\/doi.org\/10.1186\/s13756-020-0685-1.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"11","key":"740_CR29","doi-asserted-by":"publisher","first-page":"1554.e1","DOI":"10.1016\/j.cmi.2020.02.019","volume":"26","author":"MS Holland","year":"2020","unstructured":"Holland MS, Nobrega D, Peirano G, Naugler C, Church DL, Pitout JDD. Molecular epidemiology of Escherichia coli causing bloodstream infections in a centralized Canadian region: a population-based surveillance study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2020;26(11):1554.e1-1554.e8. https:\/\/doi.org\/10.1016\/j.cmi.2020.02.019.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"3","key":"740_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.14202\/vetworld.2022.662-671","volume":"15","author":"MMJ Ars\u00e8ne","year":"2022","unstructured":"Ars\u00e8ne MMJ, Davares AKL, Viktorovna PI, et al. The public health issue of antibiotic residues in food and feed: causes, consequences, and potential solutions. Vet World. 2022;15(3):662\u201371. https:\/\/doi.org\/10.14202\/vetworld.2022.662-671.","journal-title":"Vet World"},{"issue":"5","key":"740_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","volume":"20","author":"DGJ Larsson","year":"2022","unstructured":"Larsson DGJ, Flach CF. Antibiotic resistance in the environment. Nat Rev Microbiol. 2022;20(5):257\u201369. https:\/\/doi.org\/10.1038\/s41579-021-00649-x.","journal-title":"Nat Rev Microbiol"},{"key":"740_CR32","unstructured":"Antimicrobial resistance and the Iraq wars: armed conflict as an underinvestigated pathway with growing significance - PMC. Accessed April 11, 2023. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9933488\/"},{"issue":"10369","key":"740_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","volume":"400","author":"KS Ikuta","year":"2022","unstructured":"Ikuta KS, Swetschinski LR, Aguilar GR, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10369):2221\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(22)02185-7.","journal-title":"Lancet"},{"issue":"12","key":"740_CR34","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3390\/antibiotics10121478","volume":"10","author":"A Azour","year":"2021","unstructured":"Azour A, Al-Bayssari C, Dagher TN, Fajloun F, Fajloun M, Rolain JM. Clonal dissemination of plasmid-mediated carbapenem and colistin resistance in refugees living in overcrowded camps in North Lebanon. Antibiotics. 2021;10(12):1478. https:\/\/doi.org\/10.3390\/antibiotics10121478.","journal-title":"Antibiotics"},{"issue":"11","key":"740_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2217\/fmb-2021-0040","volume":"16","author":"M Osman","year":"2021","unstructured":"Osman M, Rafei R, Ismail MB, et al. Antimicrobial resistance in the protracted Syrian conflict: halting a war in the war. Future Microbiol. 2021;16(11):825\u201345. https:\/\/doi.org\/10.2217\/fmb-2021-0040.","journal-title":"Future Microbiol"},{"issue":"5","key":"740_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/antibiotics11050560","volume":"11","author":"A Shallal","year":"2022","unstructured":"Shallal A, Lahoud C, Zervos M, Matar M. Antibiotic stewardship in disaster situations: lessons learned in Lebanon. Antibiotics. 2022;11(5):560. https:\/\/doi.org\/10.3390\/antibiotics11050560.","journal-title":"Antibiotics"},{"issue":"2","key":"740_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3343\/alm.2022.42.2.203","volume":"42","author":"B Kim","year":"2022","unstructured":"Kim B, Kim JH, Lee Y. Virulence factors associated with Escherichia coli bacteremia and urinary tract infection. Ann Lab Med. 2022;42(2):203\u201312. https:\/\/doi.org\/10.3343\/alm.2022.42.2.203.","journal-title":"Ann Lab Med"},{"issue":"12","key":"740_CR38","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1093\/jac\/dkab327","volume":"76","author":"H Al-Mir","year":"2021","unstructured":"Al-Mir H, Osman M, Drapeau A, Hamze M, Madec JY, Haenni M. Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon. J Antimicrob Chemother. 2021;76(12):3135\u201343. https:\/\/doi.org\/10.1093\/jac\/dkab327.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"740_CR39","doi-asserted-by":"publisher","first-page":"e0233704","DOI":"10.1371\/journal.pone.0233704","volume":"15","author":"A Bandy","year":"2020","unstructured":"Bandy A, Almaeen AH. Pathogenic spectrum of blood stream infections and resistance pattern in gram-negative bacteria from Aljouf region of Saudi Arabia. PLoS ONE. 2020;15(6):e0233704. https:\/\/doi.org\/10.1371\/journal.pone.0233704.","journal-title":"PLoS ONE"},{"issue":"1","key":"740_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.14744\/SEMB.2018.60352","volume":"53","author":"B Bayraktar","year":"2019","unstructured":"Bayraktar B, Pelit S, Bulut ME, Akta\u015f E. Trend in antibiotic resistance of extended-spectrum beta-lactamase-producing Escherichia Coli and Klebsiella Pneumoniae bloodstream infections. Med Bull Sisli Etfal Hosp. 2019;53(1):70\u20135. https:\/\/doi.org\/10.14744\/SEMB.2018.60352.","journal-title":"Med Bull Sisli Etfal Hosp"},{"issue":"7","key":"740_CR41","doi-asserted-by":"publisher","first-page":"e0271188","DOI":"10.1371\/journal.pone.0271188","volume":"17","author":"AH Al-Jedai","year":"2022","unstructured":"Al-Jedai AH, Almogbel Y, Eljaaly K, et al. Restriction on antimicrobial dispensing without prescription on a national level: impact on the overall antimicrobial utilization in the community pharmacies in Saudi Arabia. PLoS ONE. 2022;17(7):e0271188. https:\/\/doi.org\/10.1371\/journal.pone.0271188.","journal-title":"PLoS ONE"},{"issue":"6","key":"740_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmi.2019.02.024","volume":"25","author":"B Isler","year":"2019","unstructured":"Isler B, Keske \u015e, Aksoy M, et al. Antibiotic overconsumption and resistance in Turkey. Clin Microbiol Infect. 2019;25(6):651\u20133. https:\/\/doi.org\/10.1016\/j.cmi.2019.02.024.","journal-title":"Clin Microbiol Infect"},{"key":"740_CR43","doi-asserted-by":"publisher","first-page":"105519","DOI":"10.1016\/j.micpath.2022.105519","volume":"167","author":"L Soares Moraesde","year":"2022","unstructured":"Soares Moraesde L, Gomes Magalhaes GL, Material Soncini JG, Pelisson M, Eches Perugini MR, Vespero EC. High mortality from carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Microb Pathog. 2022;167:105519. https:\/\/doi.org\/10.1016\/j.micpath.2022.105519.","journal-title":"Microb Pathog"},{"key":"740_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fmicb.2019.00276","volume":"10","author":"C Schweizer","year":"2019","unstructured":"Schweizer C, Bischoff P, Bender J, et al. Plasmid-mediated transmission of kpc-2 carbapenemase in enterobacteriaceae in critically Ill patients. Front Microbiol. 2019;10:276. https:\/\/doi.org\/10.3389\/fmicb.2019.00276.","journal-title":"Front Microbiol"},{"issue":"10","key":"740_CR45","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/AAC.01019-15","volume":"59","author":"JDD Pitout","year":"2015","unstructured":"Pitout JDD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873\u201384. https:\/\/doi.org\/10.1128\/AAC.01019-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"740_CR46","doi-asserted-by":"publisher","first-page":"001277","DOI":"10.1099\/jmm.0.001277","volume":"70","author":"MCB Quillici","year":"2021","unstructured":"Quillici MCB, Resende DS, Gon\u00e7alves IR, et al. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital. J Med Microbiol. 2021;70(1):001277. https:\/\/doi.org\/10.1099\/jmm.0.001277.","journal-title":"J Med Microbiol"},{"issue":"10","key":"740_CR47","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1517\/14656566.2014.914172","volume":"15","author":"I Karaiskos","year":"2014","unstructured":"Karaiskos I, Giamarellou H. Multidrug-resistant and extensively drug-resistant gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother. 2014;15(10):1351\u201370. https:\/\/doi.org\/10.1517\/14656566.2014.914172.","journal-title":"Expert Opin Pharmacother"},{"issue":"14","key":"740_CR48","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.3390\/app11146595","volume":"11","author":"A Fusco","year":"2021","unstructured":"Fusco A, Savio V, Stelitano D, Baroni A, Donnarumma G. The intestinal biofilm of pseudomonas aeruginosa and staphylococcus aureus is inhibited by antimicrobial peptides HBD-2 and HBD-3. Appl Sci. 2021;11(14):6595. https:\/\/doi.org\/10.3390\/app11146595.","journal-title":"Appl Sci"},{"key":"740_CR49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2015.06.024","volume":"37","author":"WI Sligl","year":"2015","unstructured":"Sligl WI, Dragan T, Smith SW. Nosocomial gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015;37:129\u201334. https:\/\/doi.org\/10.1016\/j.ijid.2015.06.024.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"740_CR50","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/antibiotics10111402","volume":"10","author":"P Di Carlo","year":"2021","unstructured":"Di Carlo P, Serra N, Lo Sauro S, et al. Epidemiology and pattern of resistance of gram-negative bacteria isolated from blood samples in hospitalized patients: a single center retrospective analysis from Southern Italy. Antibiotics. 2021;10(11):1402. https:\/\/doi.org\/10.3390\/antibiotics10111402.","journal-title":"Antibiotics"},{"key":"740_CR51","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3389\/fmicb.2019.01941","volume":"10","author":"I Dandachi","year":"2019","unstructured":"Dandachi I, Chaddad A, Hanna J, Matta J, Daoud Z. Understanding the epidemiology of multi-drug resistant gram-negative Bacilli in the middle east using a one health approach. Front Microbiol. 2019;10:1941. https:\/\/doi.org\/10.3389\/fmicb.2019.01941.","journal-title":"Front Microbiol"},{"issue":"Suppl 7","key":"740_CR52","doi-asserted-by":"publisher","first-page":"S521","DOI":"10.1093\/cid\/ciz824","volume":"69","author":"P Nordmann","year":"2019","unstructured":"Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019;69(Suppl 7):S521\u20138. https:\/\/doi.org\/10.1093\/cid\/ciz824.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"2","key":"740_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.7883\/yoken.JJID.2020.499","volume":"74","author":"T Kajihara","year":"2021","unstructured":"Kajihara T, Yahara K, Hirabayashi A, Shibayama K, Sugai M. Japan nosocomial infections surveillance (JANIS): current status, international collaboration, and future directions for a comprehensive antimicrobial resistance surveillance system. Jpn J Infect Dis. 2021;74(2):87\u201396. https:\/\/doi.org\/10.7883\/yoken.JJID.2020.499.","journal-title":"Jpn J Infect Dis"},{"key":"740_CR54","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2015.09.015","volume":"22","author":"A Xu","year":"2016","unstructured":"Xu A, Zheng B, Xu YC, Huang ZG, Zhong NS, Zhuo C. National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect. 2016;22:S1\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"740_CR55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mib.2017.10.028","volume":"39","author":"U Theuretzbacher","year":"2017","unstructured":"Theuretzbacher U. Global antimicrobial resistance in gram-negative pathogens and clinical need. Curr Opin Microbiol. 2017;39:106\u201312. https:\/\/doi.org\/10.1016\/j.mib.2017.10.028.","journal-title":"Curr Opin Microbiol"},{"issue":"11","key":"740_CR56","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1128\/AAC.00574-09","volume":"53","author":"JM Rodr\u00edguez-Mart\u00ednez","year":"2009","unstructured":"Rodr\u00edguez-Mart\u00ednez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53(11):4783\u20138. https:\/\/doi.org\/10.1128\/AAC.00574-09.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"740_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177\u201392. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.11.013.","journal-title":"Biotechnol Adv"},{"issue":"4","key":"740_CR58","doi-asserted-by":"publisher","first-page":"577","DOI":"10.53854\/liim-3004-13","volume":"30","author":"A Khedr","year":"2022","unstructured":"Khedr A, Mathew BM, Mushtaq H, et al. Pseudomonas infection reduction in the ICU: a successful multidisciplinary quality improvement project. Infez Med. 2022;30(4):577\u201386. https:\/\/doi.org\/10.53854\/liim-3004-13.","journal-title":"Infez Med"},{"key":"740_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","volume":"21\u201322","author":"A Oliver","year":"2015","unstructured":"Oliver A, Mulet X, L\u00f3pez-Causap\u00e9 C, Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Updat. 2015;21\u201322:41\u201359. https:\/\/doi.org\/10.1016\/j.drup.2015.08.002.","journal-title":"Drug Resist Updat"},{"issue":"3","key":"740_CR60","doi-asserted-by":"publisher","first-page":"e0172882","DOI":"10.1371\/journal.pone.0172882","volume":"12","author":"P Aguilar-Rodea","year":"2017","unstructured":"Aguilar-Rodea P, Z\u00fa\u00f1iga G, Rodr\u00edguez-Espino BA, et al. Identification of extensive drug resistant Pseudomonas aeruginosa strains: new clone ST1725 and high-risk clone ST233. PLoS ONE. 2017;12(3):e0172882. https:\/\/doi.org\/10.1371\/journal.pone.0172882.","journal-title":"PLoS ONE"},{"key":"740_CR61","volume-title":"Phenotypic and genotypic characteristics of clinical Pseudomonas Aeruginosa isolates","author":"H Timane","year":"2022","unstructured":"Timane H. Phenotypic and genotypic characteristics of clinical Pseudomonas Aeruginosa isolates. Beirut: Lebanese American University; 2022."},{"key":"740_CR62","doi-asserted-by":"publisher","DOI":"10.26756\/th.2017.25","volume-title":"Genome-wide antibiotic resistance and virulence profiling of Pseudomonas Aeruginosa isolated from clinical samples in Lebanon","author":"CP Harb","year":"2017","unstructured":"Harb CP. Genome-wide antibiotic resistance and virulence profiling of Pseudomonas Aeruginosa isolated from clinical samples in Lebanon. Beirut: Lebanese American University; 2017."},{"issue":"4","key":"740_CR63","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/CMR.00043-12","volume":"25","author":"L Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez L, Hancock REW. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012;25(4):661\u201381. https:\/\/doi.org\/10.1128\/CMR.00043-12.","journal-title":"Clin Microbiol Rev"},{"key":"740_CR64","unstructured":"Researchers discover how Acinetobacter baumannii can survive on hospital surfaces without water. News-Medical.net. Published May 2, 2022. Accessed April 11, 2023. https:\/\/www.news-medical.net\/news\/20220502\/Researchers-discover-how-Acinetobacter-baumannii-can-survive-on-hospital-surfaces-without-water.aspx"},{"issue":"3","key":"740_CR65","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ajic.2021.10.034","volume":"50","author":"K Cronin","year":"2022","unstructured":"Cronin K, Silkaitis C, Mikolajczak A, Bardowski L, Giannopoulos G. Developing an infection prevention program by leveraging the APIC competency model. Am J Infect Control. 2022;50(3):355\u20137. https:\/\/doi.org\/10.1016\/j.ajic.2021.10.034.","journal-title":"Am J Infect Control"},{"issue":"1","key":"740_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13031-021-00428-8","volume":"15","author":"H Lowe","year":"2021","unstructured":"Lowe H, Woodd S, Lange IL, Janjanin S, Barnet J, Graham W. Challenges and opportunities for infection prevention and control in hospitals in conflict-affected settings: a qualitative study. Confl Health. 2021;15(1):94. https:\/\/doi.org\/10.1186\/s13031-021-00428-8.","journal-title":"Confl Health"},{"issue":"5","key":"740_CR67","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jmii.2017.02.004","volume":"51","author":"CT Chen","year":"2018","unstructured":"Chen CT, Wang YC, Kuo SC, et al. Community-acquired bloodstream infections caused by Acinetobacter baumannii: a matched case-control study. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. 2018;51(5):629\u201335. https:\/\/doi.org\/10.1016\/j.jmii.2017.02.004.","journal-title":"J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi"},{"issue":"3","key":"740_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jinf.2010.07.002","volume":"61","author":"NY Lee","year":"2010","unstructured":"Lee NY, Chang TC, Wu CJ, et al. Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia. J Infect. 2010;61(3):219\u201327. https:\/\/doi.org\/10.1016\/j.jinf.2010.07.002.","journal-title":"J Infect"},{"issue":"6","key":"740_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ajic.2020.11.012","volume":"49","author":"AR Smith","year":"2021","unstructured":"Smith AR, Vowles M, Horth RZ, et al. Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah. Am J Infect Control. 2021;49(6):792\u20139. https:\/\/doi.org\/10.1016\/j.ajic.2020.11.012.","journal-title":"Am J Infect Control"},{"issue":"7","key":"740_CR70","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ajic.2017.02.005","volume":"45","author":"ML Liou","year":"2017","unstructured":"Liou ML, Chen KH, Yeh HL, Lai CY, Chen CH. Persistent nasal carriers of Acinetobacter baumannii in long-term-care facilities. Am J Infect Control. 2017;45(7):723\u20137. https:\/\/doi.org\/10.1016\/j.ajic.2017.02.005.","journal-title":"Am J Infect Control"},{"issue":"2","key":"740_CR71","doi-asserted-by":"publisher","first-page":"e00234","DOI":"10.1128\/CMR.00234-20","volume":"34","author":"CL Holmes","year":"2021","unstructured":"Holmes CL, Anderson MT, Mobley HLT, Bachman MA. Pathogenesis of gram-negative bacteremia. Clin Microbiol Rev. 2021;34(2):e00234-e320. https:\/\/doi.org\/10.1128\/CMR.00234-20.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"740_CR72","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1093\/cid\/ciaa084","volume":"71","author":"K Huh","year":"2020","unstructured":"Huh K, Chung DR, Ha YE, et al. Impact of difficult-to-treat resistance in gram-negative bacteremia on mortality: retrospective analysis of nationwide surveillance data. Clin Infect Dis. 2020;71(9):e487\u201396. https:\/\/doi.org\/10.1093\/cid\/ciaa084.","journal-title":"Clin Infect Dis"},{"key":"740_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw172.214","author":"MS Walters","year":"2016","unstructured":"Walters MS, Bulens S, Hancock EB, et al. Surveillance for carbapenem-resistant Pseudomonas aeruginosa at five United States Sites\u20142015. Open Forum Infect Dis. 2016. https:\/\/doi.org\/10.1093\/ofid\/ofw172.214.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"740_CR74","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ajic.2022.02.022","volume":"50","author":"P Eckardt","year":"2022","unstructured":"Eckardt P, Canavan K, Guran R, et al. Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit. Am J Infect Control. 2022;50(5):477\u201381. https:\/\/doi.org\/10.1016\/j.ajic.2022.02.022.","journal-title":"Am J Infect Control"},{"key":"740_CR75","unstructured":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual epidemiological report for 2021. Published November 17, 2022. Accessed April 11, 2023. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2021"},{"issue":"12","key":"740_CR76","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3390\/antibiotics9120922","volume":"9","author":"MN Al-Hasan","year":"2020","unstructured":"Al-Hasan MN. Gram-negative bloodstream infection: implications of antimicrobial resistance on clinical outcomes and therapy. Antibiotics. 2020;9(12):922. https:\/\/doi.org\/10.3390\/antibiotics9120922.","journal-title":"Antibiotics"},{"key":"740_CR77","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.2147\/IDR.S268744","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li Y, Zeng J, et al. Risk factors for mortality of inpatients with Pseudomonas aeruginosa bacteremia in China: impact of resistance profile in the mortality. Infect Drug Resist. 2020;13:4115\u201323. https:\/\/doi.org\/10.2147\/IDR.S268744.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"740_CR78","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/cid\/ciab415","volume":"73","author":"GM Wilson","year":"2021","unstructured":"Wilson GM, Suda KJ, Fitzpatrick MA, et al. Risk factors associated with carbapenemase-producing carbapenem-resistant enterobacteriaceae positive cultures in a cohort of US veterans. Clin Infect Dis. 2021;73(8):1370\u20138. https:\/\/doi.org\/10.1093\/cid\/ciab415.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"740_CR79","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.medine.2022.06.014","volume":"46","author":"E D\u00edaz Santos","year":"2022","unstructured":"D\u00edaz Santos E, Mora Jim\u00e9nez C, del R\u00edo-Carbajo L, Vidal-Cort\u00e9s P. Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections. Med Intensiva Engl Ed. 2022;46(9):508\u201320. https:\/\/doi.org\/10.1016\/j.medine.2022.06.014.","journal-title":"Med Intensiva Engl Ed"},{"issue":"12","key":"740_CR80","doi-asserted-by":"publisher","first-page":"e054971","DOI":"10.1136\/bmjopen-2021-054971","volume":"11","author":"R Zhou","year":"2021","unstructured":"Zhou R, Fang X, Zhang J, et al. Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis. BMJ Open. 2021;11(12):e054971. https:\/\/doi.org\/10.1136\/bmjopen-2021-054971.","journal-title":"BMJ Open"},{"key":"740_CR81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijid.2020.09.061","volume":"101","author":"ZY Taye","year":"2020","unstructured":"Taye ZY, Bakry MM, Bahari N. Risk factors and 30-day mortality for carbapenem-resistant Enterobacteriaceae infection, a case control study. Int J Infect Dis. 2020;101:8\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.061.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"740_CR82","doi-asserted-by":"publisher","first-page":"879.e9","DOI":"10.1016\/j.cmi.2021.12.011","volume":"28","author":"VH Mortensen","year":"2022","unstructured":"Mortensen VH, S\u00f8gaard M, Mygind LH, Wolkewitz M, Kristensen B, Sch\u00f8nheyder HC. Incidence and mortality of hospital-acquired bacteraemia: a population-based cohort study applying a multi-state model approach. Clin Microbiol Infect. 2022;28(6):879.e9-879.e15. https:\/\/doi.org\/10.1016\/j.cmi.2021.12.011.","journal-title":"Clin Microbiol Infect"},{"key":"740_CR83","unstructured":"Urinary tract infection (UTI) - Symptoms and causes. Mayo Clinic. Accessed April 11, 2023. https:\/\/www.mayoclinic.org\/diseases-conditions\/urinary-tract-infection\/symptoms-causes\/syc-20353447"},{"issue":"3","key":"740_CR84","doi-asserted-by":"publisher","first-page":"251.e1","DOI":"10.1016\/j.cmi.2015.01.001","volume":"21","author":"JK Abernethy","year":"2015","unstructured":"Abernethy JK, Johnson AP, Guy R, Hinton N, Sheridan EA, Hope RJ. Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2015;21(3):251.e1-8. https:\/\/doi.org\/10.1016\/j.cmi.2015.01.001.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"1","key":"740_CR85","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s12879-022-07436-w","volume":"22","author":"A Vivo","year":"2022","unstructured":"Vivo A, Fitzpatrick MA, Suda KJ, et al. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study. BMC Infect Dis. 2022;22(1):491. https:\/\/doi.org\/10.1186\/s12879-022-07436-w.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"740_CR86","doi-asserted-by":"publisher","first-page":"e01975","DOI":"10.1128\/aac.01975-21","volume":"66","author":"HJ Appaneal","year":"2022","unstructured":"Appaneal HJ, Lopes VV, LaPlante KL, Caffrey AR. Treatment, clinical outcomes, and predictors of mortality among a national cohort of admitted patients with Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2022;66(3):e01975-e2021. https:\/\/doi.org\/10.1128\/aac.01975-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"740_CR87","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhin.2015.10.007","volume":"92","author":"R Moghnieh","year":"2016","unstructured":"Moghnieh R, Siblani L, Ghadban D, et al. Extensively drug-resistant Acinetobacter baumannii in a Lebanese intensive care unit: risk factors for acquisition and determination of a colonization score. J Hosp Infect. 2016;92(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jhin.2015.10.007.","journal-title":"J Hosp Infect"},{"issue":"7","key":"740_CR88","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/covid4070064","volume":"4","author":"TZ Ezzeddine","year":"2024","unstructured":"Ezzeddine TZ, Ghssein G. Antibiotic misuse during the COVID-19 pandemic in Lebanon: a cross-sectional study. COVID. 2024;4(7):921\u20139. https:\/\/doi.org\/10.3390\/covid4070064.","journal-title":"COVID"},{"issue":"7","key":"740_CR89","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/covid4070064","volume":"4","author":"T Chaaban","year":"2024","unstructured":"Chaaban T, Ezzeddine Z, Ghssein G. Antibiotic misuse during the COVID-19 pandemic in Lebanon: a cross-sectional study. COVID. 2024;4(7):921\u20139. https:\/\/doi.org\/10.3390\/covid4070064.","journal-title":"COVID"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00740-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-024-00740-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-024-00740-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:02:43Z","timestamp":1728496963000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-024-00740-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1186\/s12941-024-00740-0","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Lebanese American University Institutional Review Board (IRB) approved the study. As this study exclusively involved the analysis of pre-existing, anonymised records and did not include any direct human intervention or contact, it was exempt from the requirement for ethical approval typically necessary for research involving human subjects. In addition, the study's methodology did not involve any interaction with patients, nor did it influence patient care or treatment outcomes. As such, the informed consent requirement was irrelevant to our research framework.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}